Creative Planning
- SEC CIK
- 0001540235
- Latest filing
- Aug 13, 2026
OTLK holding history
Outlook Therapeutics, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −1,094−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q4 2023 | 21,883 | $8.62K | <0.1% | +383+1.8% | Added | Holders |
| Q3 2023 | 21,500 | $4.75K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 21,500 | $37.4K | <0.1% | −1,500−6.5% | Reduced | Holders |
| Q1 2023 | 23,000 | $25.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 23,000 | $24.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 23,000 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 23,000 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 23,000 | $41.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 23,000 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 23,000 | $50.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 23,000 | $57.0K | <0.1% | −662−2.8% | Reduced | Holders |
| Q1 2021 | 23,662 | $53.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.